William Blair & Company
BMY icon

William Blair & Company’s Bristol-Myers Squibb BMY Stock Holding History

William Blair & Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,000
Closed -$56K – 1376
2017
Q2 		$56K Buy
+1,000
New +$54.4K ﹤0.01% 1463

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair & Company's BMY Position: Q1 2026 in Review

William Blair & Company increased its Bristol-Myers Squibb (BMY) stake by 16% in Q1 2026, buying an estimated $3.42M and bringing the position to 417,659 shares worth $25.3M. The position accounts for 0.07% of the portfolio, ranked #218.

William Blair & Company first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $278M in Q2 2015. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • William Blair & Company held 417,659 shares of Bristol-Myers Squibb worth $25.3M as of Q1 2026.
  • William Blair & Company bought 58,735 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.42M.
  • Bristol-Myers Squibb made up 0.07% of William Blair & Company's portfolio in Q1 2026, its #218 holding.
  • William Blair & Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • William Blair & Company's Bristol-Myers Squibb position peaked at $278M in Q2 2015.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.